Disclosures for "Electronic Assessment of Quality of Life in Glioma Patients Using the EORTC-QLQ-C30/ EORTC-BN20 and the PROMIS System in Clinical Practice"
-
Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.
-
Dr. Schultz has nothing to disclose.
-
The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Premier Applied Sciences. The institution of Dr. Snyder has received research support from Vizilitics inc.
-
Dr. Mohn has nothing to disclose.